The CTLA ‐4 immune checkpoint protein regulates PD‐L1 : PD ‐1 interaction via transendocytosis of its ligand CD80
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The
CTLA
‐4 immune checkpoint protein regulates
PD‐L1
:
PD
‐1 interaction via transendocytosis of its ligand
CD80
Authors
Keywords
-
Journal
EMBO JOURNAL
Volume -, Issue -, Pages -
Publisher
EMBO
Online
2023-02-02
DOI
10.15252/embj.2022111556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation
- (2022) Alan Kennedy et al. NATURE IMMUNOLOGY
- Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
- (2021) Murat Tekguc et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex
- (2020) Sarah C. Garrett-Thomson et al. PLoS One
- CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
- (2020) Neil Halliday et al. Frontiers in Immunology
- Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses
- (2019) Daisuke Sugiura et al. SCIENCE
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
- (2019) Yunlong Zhao et al. IMMUNITY
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects
- (2018) Charlotte Schwab et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- PD-L1 binds to B7-1 only in cis on the same cell surface
- (2018) Apoorvi Chaudhri et al. Cancer Immunology Research
- Characterization of CTLA4 Trafficking and Implications for Its Function
- (2018) Sahamoddin Khailaie et al. BIOPHYSICAL JOURNAL
- Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80
- (2018) Kaniel Cassady et al. Frontiers in Immunology
- PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells
- (2017) Xiong Ni et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- A Transendocytosis Model of CTLA-4 Function Predicts Its Suppressive Behavior on Regulatory T Cells
- (2015) Tie Zheng Hou et al. JOURNAL OF IMMUNOLOGY
- Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
- (2015) B. Lo et al. SCIENCE
- Confusing signals: Recent progress in CTLA-4 biology
- (2015) Lucy S.K. Walker et al. TRENDS IN IMMUNOLOGY
- Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
- (2014) Desirée Schubert et al. NATURE MEDICINE
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
- (2014) H. S. Kuehn et al. SCIENCE
- Structure and Interactions of the Human Programmed Cell Death 1 Receptor
- (2013) Xiaoxiao Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
- (2012) Omar S. Qureshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
- (2011) A. M. Paterson et al. JOURNAL OF IMMUNOLOGY
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Preferential Transfer of Certain Plasma Membrane Proteins onto T and B Cells by Trogocytosis
- (2010) Sandrine Daubeuf et al. PLoS One
- Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells
- (2008) A. Aucher et al. BLOOD
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
- Structures of PD-1 with its ligands: Sideways and dancing cheek to cheek
- (2008) G. J. Freeman PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
- (2008) D. Y.-w. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started